ANAVEX-1005

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameANAVEX-1005
Drug Alias NameANAVEX-1005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSigma-2 receptor modulators
TargetsSigma-2 receptor
Therapy Area/IndicationsNeuralgiaPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnavex Life Sciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnavex Life Sciences Corp
Active IndicationsN/A
Inactive IndicationsNeuralgiaPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A